BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jean SS, Ko WC, Lee WS, Lu MC, Hsueh PR; SMART Program. Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020. Expert Rev Anti Infect Ther 2021. [PMID: 34933656 DOI: 10.1080/14787210.2022.2021876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Losito AR, Raffaelli F, Del Giacomo P, Tumbarello M. New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review. Antibiotics 2022;11:579. [DOI: 10.3390/antibiotics11050579] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Jean S, Harnod D, Hsueh P. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Front Cell Infect Microbiol 2022;12:823684. [DOI: 10.3389/fcimb.2022.823684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]